III. Identification of novel CXCR3 chemokine receptor antagonists with a pyrazinyl–piperazinyl–piperidine scaffold
Graphical abstract
References and notes (12)
- et al.
Curr. Top. Dev. Biol.
(2005)et al.Mini-Rev. Med. Chem.
(2007) - et al.
Cytokine
(2001) J. Exp. Med.
(1996)J. Exp. Med.
(1998)et al.Acta Neurol. Scand.
(2007)
There are more references available in the full text version of this article.
Cited by (15)
II. Discovery of a novel series of CXCR3 antagonists with a beta amino acid core
2016, Bioorganic and Medicinal Chemistry LettersIV. Discovery of CXCR3 antagonists substituted with heterocycles as amide surrogates: Improved PK, hERG and metabolic profiles
2014, Bioorganic and Medicinal Chemistry LettersA review of the pleiotropic actions of the IFN-inducible CXC chemokine receptor 3 ligands in the synovial microenvironment
2023, Cellular and Molecular Life SciencesDesigning small molecule CXCR3 antagonists
2017, Expert Opinion on Drug Discovery
Copyright © 2011 Elsevier Ltd. All rights reserved.